| 前收市價 | 4.83 |
| 開市 | 5.16 |
| 買盤 | 5.15 |
| 賣出價 | 5.25 |
| 拍板 | 12.00 |
| 到期日 | 2024-09-20 |
| 今日波幅 | 5.15 - 5.16 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 403 |
InvestorPlacePatent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are trying to keep generic drugs at bay from their branded products. The Biden administration is attacking businesses across the board, such as its recent assault on the oil industry. Yet it risks killing off the drug discovery market with its actions by disincentivizing companies to find new treatments. For example, inventors of technology developed with federal funding retain
ZacksIs Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Teva Pharmaceutical Industries Ltd. (TEVA) have performed compared to their sector so far this year.
ZacksShould Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
